Literature DB >> 24915955

Hotline update of clinical trials and registries presented at the American College of Cardiology Congress 2014.

Dirk Westermann1, Reinhold Kreutz, Claudius Jacobshagen.   

Abstract

This article provides information and commentaries on trials which were presented at the Hotline and Clinical Trial Update Sessions during the Late Breaking Clinical Trial Sessions at the 63rd annual meeting of the American College of Cardiology in Washington, USA, from 29th to 31st March 2014. This article gives an overview on a number of novel clinical trials in the field of cardiovascular medicine, which were presented. Comprehensive summaries have been generated from the oral presentation and the webcasts of the American College of Cardiology, similar to as previously reported and should provide the readers with the most comprehensive information of relevant publications. The discussed studies are US CoreValve, Choice, Symplcity-HTN-3, GRS, ZEUS, GIPS-III, HEAT-PPCI, COPR-2, MSC-HF, POISE-2, SIRS. The data were presented by leading experts in the field.

Entities:  

Mesh:

Year:  2014        PMID: 24915955     DOI: 10.1007/s00392-014-0733-z

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  28 in total

1.  Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.

Authors:  Martin B Leon; Craig R Smith; Michael Mack; D Craig Miller; Jeffrey W Moses; Lars G Svensson; E Murat Tuzcu; John G Webb; Gregory P Fontana; Raj R Makkar; David L Brown; Peter C Block; Robert A Guyton; Augusto D Pichard; Joseph E Bavaria; Howard C Herrmann; Pamela S Douglas; John L Petersen; Jodi J Akin; William N Anderson; Duolao Wang; Stuart Pocock
Journal:  N Engl J Med       Date:  2010-09-22       Impact factor: 91.245

2.  Transcatheter versus surgical aortic-valve replacement in high-risk patients.

Authors:  Craig R Smith; Martin B Leon; Michael J Mack; D Craig Miller; Jeffrey W Moses; Lars G Svensson; E Murat Tuzcu; John G Webb; Gregory P Fontana; Raj R Makkar; Mathew Williams; Todd Dewey; Samir Kapadia; Vasilis Babaliaros; Vinod H Thourani; Paul Corso; Augusto D Pichard; Joseph E Bavaria; Howard C Herrmann; Jodi J Akin; William N Anderson; Duolao Wang; Stuart J Pocock
Journal:  N Engl J Med       Date:  2011-06-05       Impact factor: 91.245

3.  Safety and efficacy of the subclavian access route for TAVI in cases of missing transfemoral access.

Authors:  Andrea Muensterer; Domenico Mazzitelli; Hendrik Ruge; Anke Wagner; Ina Hettich; Nicolo Piazza; Ruediger Lange; Sabine Bleiziffer
Journal:  Clin Res Cardiol       Date:  2013-05-11       Impact factor: 5.460

4.  Comparing outcome of patients with coronary artery disease and dilated cardiomyopathy in ICD and CRT recipients: data from the German DEVICE-registry.

Authors:  Kristina Wasmer; Julia Köbe; Dietrich Andresen; Ralf Zahn; Stefan G Spitzer; Joachim Jehle; Johannes Brachmann; Christoph Stellbrink; Eimo Martens; Matthias Hochadel; Jochen Senges; Helmut Klein; Lars Eckardt
Journal:  Clin Res Cardiol       Date:  2013-03-30       Impact factor: 5.460

5.  Transcatheter aortic-valve replacement with a self-expanding prosthesis.

Authors:  David H Adams; Jeffrey J Popma; Michael J Reardon; Steven J Yakubov; Joseph S Coselli; G Michael Deeb; Thomas G Gleason; Maurice Buchbinder; James Hermiller; Neal S Kleiman; Stan Chetcuti; John Heiser; William Merhi; George Zorn; Peter Tadros; Newell Robinson; George Petrossian; G Chad Hughes; J Kevin Harrison; John Conte; Brijeshwar Maini; Mubashir Mumtaz; Sharla Chenoweth; Jae K Oh
Journal:  N Engl J Med       Date:  2014-03-29       Impact factor: 91.245

6.  Effect of gender differences on 1-year mortality after transcatheter aortic valve implantation for severe aortic stenosis: results from a multicenter real-world registry.

Authors:  Mohammad A Sherif; Ralf Zahn; Ulrich Gerckens; Horst Sievert; Holger Eggebrecht; Rainer Hambrecht; Stefan Sack; Gert Richardt; Steffen Schneider; Jochen Senges; Johannes Brachmann
Journal:  Clin Res Cardiol       Date:  2014-03-06       Impact factor: 5.460

7.  The groin first approach for transcatheter aortic valve implantation: are we pushing the limits for transapical implantation?

Authors:  Carsten J Beller; Bastian Schmack; Philipp Seppelt; Rawa Arif; Raffi Bekeredjian; Ulrike Krumsdorf; Hugo A Katus; Matthias Karck; Klaus Kallenbach
Journal:  Clin Res Cardiol       Date:  2012-08-05       Impact factor: 5.460

8.  Edwards Sapien XT valve placement as treatment option for aortic regurgitation after transfemoral CoreValve implantation: a multicenter experience.

Authors:  Patrick Diemert; Philipp Lange; Martin Greif; Moritz Seiffert; Lenard Conradi; Steffen Massberg; Stefan Blankenberg; Hermann Reichenspurner; Christian Hagl; Christoph Schmitz; Holger Schröfel; Hendrik Treede; Gerhard Schymik; Christian Kupatt
Journal:  Clin Res Cardiol       Date:  2013-11-20       Impact factor: 5.460

9.  Development of a risk score for outcome after transcatheter aortic valve implantation.

Authors:  Moritz Seiffert; Jan-Malte Sinning; Alexander Meyer; Sandra Wilde; Lenard Conradi; Mariuca Vasa-Nicotera; Alexander Ghanem; Jörg Kempfert; Christoph Hammerstingl; Francisco M Ojeda; Won-Keun Kim; Dietmar H Koschyk; Johannes Schirmer; Stephan Baldus; Eberhard Grube; Helge Möllmann; Hermann Reichenspurner; Georg Nickenig; Stefan Blankenberg; Patrick Diemert; Hendrik Treede; Thomas Walther; Nikos Werner; Renate B Schnabel
Journal:  Clin Res Cardiol       Date:  2014-03-19       Impact factor: 5.460

Review 10.  Worldwide TAVI registries: what have we learned?

Authors:  Stephan Haussig; Gerhard Schuler; Axel Linke
Journal:  Clin Res Cardiol       Date:  2014-03-20       Impact factor: 5.460

View more
  1 in total

1.  How does a clinical trial fit into the real world? The RELAX-AHF study population into the EAHFE registry.

Authors:  Òscar Miró; Víctor Gil; Christian Müller; Alexander Mebazaa; Héctor Bueno; Francisco Javier Martín-Sánchez; Pablo Herrero; Javier Jacob; Pere Llorens
Journal:  Clin Res Cardiol       Date:  2015-04-24       Impact factor: 5.460

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.